Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.375
+0.085 (3.71%)
Apr 10, 2026, 1:20 PM EDT - Market open
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $305.52 million as of April 10, 2026. Its market cap has decreased by -53.85% in one year.
Market Cap
305.52M
Enterprise Value
291.09M
1-Year Change
-53.85%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $305.52M, a decrease of -75.29%. That is a compound annual growth rate of -17.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 294.59M | -55.19% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 510.15M |
| Kamada | 476.75M |
| Emergent BioSolutions | 431.75M |
| Canopy Growth | 387.76M |
| Akebia Therapeutics | 380.39M |
| SIGA Technologies | 323.83M |
| Evolus | 262.52M |
| Anika Therapeutics | 202.62M |